# ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial

> **NCT02326350** · PHASE2 · TERMINATED · sponsor: **Belfast Health and Social Care Trust** · enrollment: 49 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Aspirin 75mg
- **DRUG:** Lactose powder

## Key facts

- **NCT ID:** NCT02326350
- **Lead sponsor:** Belfast Health and Social Care Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02-06
- **Primary completion:** 2018-11-23
- **Final completion:** 2018-11-23
- **Target enrollment:** 49 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2019-03-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02326350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02326350, "ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02326350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*